News from USA
|
DRUG |
COMPANY |
NEWS |
|
Hydroxychloroquine Sulfate |
Lupin Pharma |
Lupin receives FDA approval for generic Hydroxychloroquine Sulfate Tablets USP, 200 mg |
|
Rivastigmine |
Mylan |
Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon Patch |
|
Budesonide |
Teva Pharma |
Teva Announces Launch of a Generic Version of Uceris in the United States
|
Other ANDA Approvals
|
DRUG |
COMPANY |
Corresponding RLD |
|
Adefovir Dipivoxil |
Apotex |
Hepsera(Gilead) |
|
Epinephrine |
Luitpold Pharms |
Adrenalin (Par Pharma) |
|
Docetaxel |
Mylan |
Docetaxel (Hospira) |
Tentative Approvals
|
DRUG |
COMPANY |
Corresponding RLD |
|
Dolutegravir |
Mylan |
Tivicay (Viv Healthcare) |
|
Dextromethorphan Hydrobromide; Guaifenesin |
Amneal Pharma |
Mucinex Dm (Reckitt Benckiser) |
*For browsing official press releases click on the respective news item.
This is a very useful post shared by you. Thanks for providing such a valuable information with us.
ReplyDelete